Our £50,000 investment in Solid Biosciences

We are so pleased to be able to share with you an update from Solid Biosciences, the company that developed a gene therapy treatment for Duchenne Muscular Dystrophy.  As a result of this investment, alongside other Duchenne charities, Biosciences have completed their preclinical trials with positive data.  This is such fabulous news as it means that they will be able to start testing this potential medicine on boys THIS YEAR!
This is fabulous news for the whole Duchenne Community and we would like to thank you – our supporters – for helping to make this happen.